We look for clarity on:
* the pain point in the pharma or life-sciences you are addressing,
* how AI, data, or tech enables a defensible competitive moat,
* market size (≥ $1B TAM preferred, strong growth trajectory),
* capital efficiency and margins (software-oriented businesses or scalable services),
* a credible commercialization or exit pathway, and
* a transparent use of capital plan with clear milestones and runway.
If your deck addresses those items concisely, you will catch our attention!